Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-113867
Filing Date
2023-04-25
Accepted
2023-04-25 06:05:50
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d422732ddefa14a.htm DEFA14A 66032
2 GRAPHIC g422732g04v77.jpg GRAPHIC 26907
3 GRAPHIC g422732g06j74.jpg GRAPHIC 115475
4 GRAPHIC g422732snap1.jpg GRAPHIC 4838
  Complete submission text file 0001193125-23-113867.txt   267131
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 23841543
SIC: 2836 Biological Products, (No Diagnostic Substances)